BABA is the China ADR stress test: e-commerce + cloud + regulatory regime risk. Rising “baba stock” searches still need VIE and policy falsifiers — not a US mega-cap paste.
Templeton emerging-market pessimism vs growth seats on cloud/AI attach. Value seats ask whether the multiple prices permanent political risk.
VIE structure, regulatory headlines, ADR delisting/liquidity risk, and segment mix (China commerce vs cloud). Confirm ADR class.
Independent briefs, then clerk assembly · 3 isolated prompts + 1 assembly pass · filing facts from SEC EDGAR (cached 7 days) — not investment advice, no buy button
Preview seating. Paid desks are 16 / 29 / 48 / 61. $49 is Associate (29), not 61. Partners is the same 61 with more compute.
Alibaba Group Holding Ltd · 20-F FY · FY2026 · ended 2026-03-31 · CIK 0001577552
Filings from SEC companyfacts (us-gaap). P/B, P/S from cached price × diluted shares vs filings. Not a live quote. Not a live quote, not advice, not a buy button. Missing numbers stay blank; P/E shows n/m when diluted EPS ≤ 0.
Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Cautious — the file is open, the bar is not cleared. Owner test on BABA: P/E 124.5, P/B 12.46, ROE 9.8%, net income $15.0B. Region: China.
Question: “Research BABA as a US-listed emerging-market name.”. Owner earnings lens on BABA. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass. Numbers on file: P/E 124.5; P/B 12.46; ROE 9.8%; net income $15.0B; revenue YoY 8.1%. On file: 20-F FY FY2026; revenue $148.4B; revenue YoY 8.1%; net income $15.0B; ROE 9.8%; P/E 124.5; P/B 12.5; P/S 12.9; price $99.64 cached. A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk. Underwrite frame: Worth further homework. EM overlay: China · Platform + cloud. ADR is the US window. Research the franchise, the regulator, and the listing structure separately. Kill-shot unique to this listing: The variable-interest structure or policy makes residual claims unownable.. Isolated: I am not averaging a country ETF view with this name.
Constructive — the work is worth continuing, not an order. Classify BABA before cheering growth. revenue YoY 8.1%. P/E 124.5. Region: China.
Question: “Research BABA as a US-listed emerging-market name.”. Classify before multiple. Six-category company classification system.. revenue YoY 8.1%. P/E 124.5. revenue $148.4B. On file: 20-F FY FY2026; revenue $148.4B; revenue YoY 8.1%; net income $15.0B; ROE 9.8%; P/E 124.5; P/B 12.5; P/S 12.9; price $99.64 cached. Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay. Underwrite frame: Worth further homework. EM overlay: China · Platform + cloud. ADR is the US window. Research the franchise, the regulator, and the listing structure separately. Kill-shot unique to this listing: The variable-interest structure or policy makes residual claims unownable.. Isolated: I am not averaging a country ETF view with this name.
Skeptical — the burden of proof is on the bull case. Invert BABA first. What has to be false for the bull to die? Region: China.
Question: “Research BABA as a US-listed emerging-market name.”. Invert BABA. Invert: how would this thesis get killed? List the kill-shots before the romance. On file: 20-F FY FY2026; revenue $148.4B; revenue YoY 8.1%; net income $15.0B; ROE 9.8%; P/E 124.5; P/B 12.5; P/S 12.9; price $99.64 cached. Name what must be true for the bull: earnings quality, leverage (D/E not on file), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job. Underwrite frame: Pass for now. EM overlay: China · Platform + cloud. ADR is the US window. Research the franchise, the regulator, and the listing structure separately. Kill-shot unique to this listing: The variable-interest structure or policy makes residual claims unownable.. Isolated: I am not averaging a country ETF view with this name.
Isolated views — not a vote and not advice
Peter Lynch stays constructive (Constructive — the work is worth continuing, not an order. Classify BABA before cheering …); Charlie Munger stays skeptical (Skeptical — the burden of proof is on the bull case. Invert BABA first. What has to be fa…). Split kept — not averaged.
Warren Buffett leans bull-frame; Peter Lynch leans kill/falsifier frame. Isolated views — clerk does not pick a winner.
Warren Buffett leans bull-frame; Charlie Munger leans kill/falsifier frame. Isolated views — clerk does not pick a winner.
Clerk stacks the split. Confidence is never averaged into a recommendation.
Counted from isolated briefs. Ratios are filings or cached model input — not a live quote, not a rating, not a buy button.
| Metric | Value | Note |
|---|---|---|
| P/E | 124.5 | P/B, P/S from cached price × diluted shares vs filings. Not a live quote. |
| P/B | 12.46 | P/B, P/S from cached price × diluted shares vs filings. Not a live quote. |
| P/S | 12.91 | — |
| ROE | 9.8% | — |
| LT debt / equity | — | — |
| Revenue (FY) | $148.4B | — |
| Revenue YoY | +8.1% | — |
| Net income | $15.0B | — |
| Diluted EPS | $0.80 | — |
Cycle, timing, exit, and quant seats are dark on this plan. A three-seat sample cannot locate the cycle or size a position.
Assembly is a second isolated pass over the briefs. Masters did not read each other. Research simulation — not advice, not a buy button.
Analyst unlocks 16 independent seats (16 isolated prompts + 1 assembly pass).
See AnalystCounted from independent briefs only — not a vote, not a recommendation.
Trend research (Wood, Laffont, and the rest of the era desk) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansCycle desk (Dalio, Marks, Templeton) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansWarren BuffettBABA: screened alone against Moat & Management Final Review.
Peter LynchBABA: screened alone against Ten-Bagger Hunter.
Debate starts only after independent briefs exist. Red team still does not see a shared draft.
Charlie Munger — Debate chair · inversion: the best way to kill this thesis
Warren Buffett — Final review · 10-year hold test
Full transcript, risk list, and sizing stay on higher seats.
Unlock more seatsTiming desk (O’Neil and the tape seats) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansExit desk (Livermore, Darvas, Bogle accountability) is locked on Observer.
Unlocks on Committee or Partners (61). Empty seats stay empty — we do not ghost-fill them.
Compare plansQuant (Thorp Kelly sizing, then the full seven on Committee) is locked on Observer.
Unlocks on Analyst (16). Empty seats stay empty — we do not ghost-fill them.
Compare plansAgents61 is a research simulation and educational tool. Isolated views, splits, and assembly notes only. Not personalized advice. AI-generated.
